(PharmaNewsWire.Com, May 08, 2017 ) According to the report HIV Therapeutic Market, published by Market Data Forecast, the global market is projected to reach USD 14.2 Billion by 2021, at a CAGR of 1.4% from 2016 to 2021.The human immunodeficiency infection (HIV) refers to a kind of retrovirus that causes (AIDS). HIV assaults some immune cells and it weakens immune system bringing about loss of capacity to fight against the organisms that causes diseases. HIV contamination has no cure however there are medicines which help to balance out or decrease this infection so it doesn't prompt to AIDS. HIV therapeutics market is developing at a significant rate because of increment in the HIV contaminated cases and developing awareness about the same. HIV disease can be treated with different therapeutics.
Increasing number of HIV affected cases, innovative advancement in HIV diagnosis and therapeutics, ascend in research exercises for developing HIV immunizations and not aware about the methods of transmission of the infection are driving the worldwide market for HIV therapeutics. Different variables, for example, disappointment of treatment sometimes, absence of gifted experts and presentation of non-specific medications in the market are major restraints the HIV therapeutics market.
Major players involved in managing in HIV therapeutics are GlaxoSmithKline, Bristol-Myers Squibb, Pfizer and Boehringer Ingelheim. Other organizations having huge presence in HIV therapeutics market are Merck, Hoffmann-La Roche and Gilead Sciences.
About us: Market Data Forecast is a firm working in the areas of market research and business intelligence. We have rich experience in research across major industry segments like Healthcare, Agriculture, Food & Beverages etc. and we cater to the needs of both individual and corporate clients. Our research services contribute to key business areas like business process improvement, key decision making and developing an appropriate corporate strategy. We are truly committed to our clients and other stakeholders for providing customized research services of the highest quality all the while being an organization that’s trusted for its integrity, respected for its accountability, and admired for its excellence, by both clients and competitors alike.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
